BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc.

Share · US1079241022 · BBOT (XNAS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BridgeBio Oncology Therapeutics Inc.
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
3
0
0
0
No Price
28.04.2026 20:00
Current Prices from BridgeBio Oncology Therapeutics Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
BBOT
USD
28.04.2026 20:00
8,80 USD
0,01 USD
+0,11 %
IEXG: IEX
IEX
BBOT
USD
28.04.2026 19:59
8,83 USD
0,04 USD
+0,40 %
Share Float & Liquidity
Free Float 0,57 %
Shares Float 452.573,00
Shares Outstanding 80,03 M
Company Profile for BridgeBio Oncology Therapeutics Inc. Share
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapeutics targeting RAS and PI3Kα malignancies, which are prevalent oncogenes in human tumors. Initially formed as a subsidiary of BridgeBio Pharma, it focuses on precision oncology with a pipeline that includes BBO-8520, BBO-10203, and BBO-11818 programs targeting KRAS and PI3K pathways. The company recently went public through a business combination with Helix Acquisition Corp. II, raising approximately $450 million to advance clinical development. The CEO is Dr. Eli Wallace, and the CSO is Dr. Pedro Beltran.

Company Data

Name BridgeBio Oncology Therapeutics Inc.
Company BridgeBio Oncology Therapeutics Inc.
Symbol BBOT
Website https://bbotx.com
Primary Exchange XNAS NASDAQ
ISIN US1079241022
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Eli M. Wallace
Market Capitalization 704 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 256 E. Grand Avenue, 94080 South San Francisco
IPO Date 2025-08-12

ID Changes

Date From To
12.08.2025 HLXB BBOT

Ticker Symbols

Name Symbol
NASDAQ BBOT
More Shares
Investors who hold BridgeBio Oncology Therapeutics Inc. also have the following shares in their portfolio:
ADVANTAGEWON OIL CORP
ADVANTAGEWON OIL CORP Share
GREECE (KINGDOM OF) 7% 1924 STLG FDG BDS 1965
GREECE (KINGDOM OF) 7% 1924 STLG FDG BDS 1965 Bond